Under depression conditions, the expression of GRs decreases, which weakens the inhibition of the HPA axis, leading to the excessive activation of the HPA axis, thereby increasing the levels of CRH, ACTH, CORT, and GC in the patients with depression and affecting the secretion in vivo [85, 86]. Here, BCL2A1 is linked to depressive symptom measurement.